Microorganisms in the aetiology of atherosclerosis

被引:43
作者
Morré, SA
Stooker, W
Lagrand, WK
van den Brule, AJC
Niessen, HWM
机构
[1] Free Univ Amsterdam Hosp, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Cardiac Surg, Amsterdam, Netherlands
[3] Free Univ Amsterdam Hosp, Dept Cardiol, Amsterdam, Netherlands
关键词
atherosclerosis; Chlamydia pneumoniae; Helicobacter pylori;
D O I
10.1136/jcp.53.9.647
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent publications have suggested that infective pathogens might play an important role in the pathogenesis of atherosclerosis. This review focuses on these microorganisms in the process of atherosclerosis. The results of in vitro studies, animal studies, tissue studies, and serological studies will be summarised, followed by an overall conclusion concerning the strength of the association of the microorganism with the pathogenesis of atherosclerosis. The role of the bacteria Chlamydia pneumoniac and Helicobacter pylori, and the viruses human immunodeficiency virus, coxsackie B virus, cytomegalovirus, Epstein-Barr virus, herpes simplex virus, and measles virus will be discussed.
引用
收藏
页码:647 / 654
页数:8
相关论文
共 116 条
[1]  
ADAM E, 1987, LANCET, V2, P291
[2]  
Adam E, 1997, Cent Eur J Public Health, V5, P99
[3]   CAROTID INTIMA-MEDIA THICKNESS IS ONLY WEAKLY CORRELATED WITH THE EXTENT AND SEVERITY OF CORONARY-ARTERY DISEASE [J].
ADAMS, MR ;
NAKAGOMI, A ;
KEECH, A ;
ROBINSON, J ;
MCCREDIE, R ;
BAILEY, BP ;
BENFREEDMAN, S ;
CELERMAJER, DS .
CIRCULATION, 1995, 92 (08) :2127-2134
[4]   Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis [J].
Adler, SP ;
Hur, JK ;
Wang, JB ;
Vetrovec, GW .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (01) :209-212
[5]   Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease [J].
Altman, R ;
Rouvier, J ;
Scazziota, A ;
Absi, RS ;
Gonzalez, C .
CLINICAL CARDIOLOGY, 1999, 22 (02) :85-90
[6]   Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study [J].
Anderson, JL ;
Muhlestein, JB ;
Carlquist, J ;
Allen, A ;
Trehan, S ;
Nielson, C ;
Hall, S ;
Brady, J ;
Egger, M ;
Horne, B ;
Lim, T .
CIRCULATION, 1999, 99 (12) :1540-1547
[7]   Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery [J].
Andreasen, JJ ;
Farholt, S ;
Jensen, JS .
APMIS, 1998, 106 (07) :717-720
[8]   Chlamydia infections and heart disease linked through antigenic mimicry [J].
Bachmaier, K ;
Neu, N ;
de la Maza, LM ;
Pal, S ;
Hessel, A ;
Penninger, JM .
SCIENCE, 1999, 283 (5406) :1335-1339
[9]   Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts [J].
Bartels, C ;
Maass, M ;
Bein, G ;
Malisius, R ;
Brill, N ;
Bechtel, JFM ;
Sayk, F ;
Feller, AC ;
Sievers, HH .
CIRCULATION, 1999, 99 (07) :879-882
[10]  
BAYAD J, 1993, ANN BIOL CLIN-PARIS, V51, P101